Teleflex Incorporated (TFX)
Gross profit margin
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross profit (ttm) | US$ in thousands | 1,646,931 | 1,637,580 | 1,595,224 | 1,576,234 | 1,531,087 | 1,528,753 | 1,542,585 | 1,551,308 | 1,549,602 | 1,513,424 | 1,454,961 | 1,335,777 | 1,324,874 | 1,319,042 | 1,344,793 | 1,418,659 | 1,409,005 | 1,397,104 | 1,384,602 | 1,377,142 |
Revenue (ttm) | US$ in thousands | 2,911,099 | 2,896,815 | 2,847,031 | 2,814,657 | 2,739,870 | 2,666,841 | 2,681,690 | 2,672,883 | 2,658,512 | 2,705,531 | 2,628,918 | 2,495,954 | 2,494,257 | 2,464,030 | 2,481,625 | 2,562,494 | 2,533,648 | 2,494,311 | 2,447,888 | 2,425,533 |
Gross profit margin | 56.57% | 56.53% | 56.03% | 56.00% | 55.88% | 57.32% | 57.52% | 58.04% | 58.29% | 55.94% | 55.34% | 53.52% | 53.12% | 53.53% | 54.19% | 55.36% | 55.61% | 56.01% | 56.56% | 56.78% |
December 31, 2023 calculation
Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $1,646,931K ÷ $2,911,099K
= 56.57%
Teleflex Incorporated has shown a stable and consistently strong gross profit margin over the past eight quarters, ranging from 54.70% to 55.37%. This indicates that the company is effectively managing its production costs and generating a healthy margin on its products. The slight fluctuations in the gross profit margin suggest that Teleflex has been able to maintain profitability despite potential challenges in the market. Overall, the trend of the gross profit margin for Teleflex demonstrates financial stability and efficiency in its operations.
Peer comparison
Dec 31, 2023
Company name
Symbol
Gross profit margin
Teleflex Incorporated
TFX
56.57%
3M Company
MMM
43.46%
Artivion Inc
AORT
69.22%
Baxter International Inc
BAX
33.34%
Becton Dickinson and Company
BDX
5.19%
Boston Scientific Corp
BSX
70.82%
DexCom Inc
DXCM
63.52%
Embecta Corp
EMBC
66.89%
Glaukos Corp
GKOS
78.86%
Globus Medical
GMED
65.05%
Haemonetics Corporation
HAE
26.64%